SCHEMBL4974097

SCHEMBL4974097

O=C(O)N1CCCC([C@@H](OCCO)c2cccc(F)c2)C1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
REN P00797 19/20 0.53
CYP3A4 P08684 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4978806 1.00 REN (0.53) RENCYP3A4
SCHEMBL4970186 0.91 REN (0.55) RENCYP3A4
SCHEMBL4970187 0.91 REN (0.55) RENCYP3A4
SCHEMBL4973087 0.88 REN (0.57) RENCYP3A4
SCHEMBL4973080 0.88 REN (0.57) RENCYP3A4
SCHEMBL2328618 0.86 REN (0.51) RENCYP3A4
SCHEMBL2325002 0.86 REN (0.53) RENCYP3A4
SCHEMBL2325007 0.86 REN (0.53) RENCYP3A4
SCHEMBL2325014 0.86 REN (0.53) RENCYP3A4
SCHEMBL2328616 0.86 REN (0.51) RENCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed